According to Basilea Pharmaceutica's latest financial reports the company's total liabilities are S$0.25 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | S$0.28 B | -17.87% |
2022-12-31 | S$0.35 B | -22.54% |
2021-12-31 | S$0.45 B | -9.12% |
2020-12-31 | S$0.49 B | 13.79% |
2019-12-31 | S$0.43 B | -9.57% |
2018-12-31 | S$0.48 B | -10.26% |
2017-12-31 | S$0.53 B | 4.64% |
2016-12-31 | S$0.51 B | -6.23% |
2015-12-31 | S$0.54 B | 106.16% |
2014-12-31 | S$0.26 B | -18.44% |
2013-12-31 | S$0.32 B | -9.61% |
2012-12-31 | S$0.36 B | 212.49% |
2011-12-31 | S$0.11 B | -21.03% |
2010-12-31 | S$0.14 B | -0.86% |
2009-12-31 | S$0.14 B | -16.05% |
2008-12-31 | S$0.17 B | 9.61% |
2007-12-31 | S$0.16 B | 40.37% |
2006-12-31 | S$0.11 B | 3.11% |
2005-12-31 | S$0.11 B | 266.25% |
2004-12-31 | S$30.29 M | 31.81% |
2003-12-31 | S$22.98 M | -58.15% |
2002-12-31 | S$54.92 M |